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Background
Prevalence of non-Hodgkin’s lymphoma (NHL) sub-
groups throughout Africa, particularly among persons
with HIV/AIDS, is unknown but increases in Burkitt
lymphoma, plasmablastic lymphoma, and HHV-8 prolif-
eration disorders have been noted. SSALC, an AIDS and
Cancer Specimen Resource (ACSR/NCI) project, seeks
to define indigenous sub-Saharan NHL subtypes using
WHO classification (2008). Omoti (Univ. Benin 2007)
defined an overall malignant lymphoma (ML) rate: 13.4/
100,000 (1990s) including 17% Hodgkin’s disease and
83% NHL but subgroups were not defined. Because
regional HIV/AIDS prevalence is high, we subgrouped
NHL and reviewed lymph node hyperplasia using stored
material from Ahmadu Bello University Teaching Hos-
pital in Zaria, Nigeria, to look for HIV/AIDS-associated
lymphoid malignancies.
Materials and methods
Fifty-seven paraffin blocks were used to construct a tissue
microarray (TMA), and whole tissue sections were H&E
stained for morphology. TMA sections were stained
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Table 1 Cases by diagnostic subgroup
Subgroups N %NHL
Burkitt lymphoma 19 51
Lymphoblastic lymphoma: (pre-B) 1 3
Angioimmunoblastic T-cell lymphoma 1 3
Follicular lymphoma 6 16
NHL Marginal zone lymphoma 1 3
ML Lymphoma not otherwise specified (NOS) 2 5
B-cell lymphoma, EBV+ 1 3
Diffuse large B-cell lymphoma Activated B cell 4 11
NOS 1 3
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gens and Lana-1 for HHV-8 (immunohistochemical,
IHC); in situ hybridization (ISH) for EBV-encoded RNA,
kappa/lambda light chains (Ventana, Tucson, AZ), and
fluorescent in situ hybridization (FISH) c-myc t(8;14)
(Abbott/Vysis, Downer’s Grove, IL).
Results
There were 43 ML and 14 hyperplasic lymph nodes or
reactive tissues. One lymph node was suspected for Cas-
tleman’s disease but Lana-1 was negative. Table 1 lists
ML subgroups.
Conclusions
Subgrouping ML with Hodgkin’s disease (12%) and
NHL (88%) is similar to the 2007 report from nearby
Benin University. Burkitt lymphoma was the most com-
mon NHL at 51% followed by follicular lymphoma 16%
and diffuse large B-cell lymphomas 14%. With the
exception of Burkitt lymphoma, which is endemic in
Nigeria, other NHL commonly associated with HIV/
AIDS such as plasmablastic lymphoma and HHV-8 lym-
phoproliferative disorders were not identified.
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